| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
4 companies
Gilbert S Omenn is Director at AMST, with reported holdings spanning 4 companies. Gilbert S Omenn's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $470K at current prices.
Our model assigns Gilbert S Omenn a below-average insider score of 17/100, based on 3 past trades. Over a 12-month horizon, none of those trades were profitable, with an average 12-month return of -60.6%.
Gilbert S Omenn's largest disclosed position is in GALT as Director, worth about $224K. The GALT filings lean toward selling, a net 792 shares.
Gilbert S Omenn has 49 Form 4 filings on record from March 2015 to September 2026, across 4 companies: Director at Amesite (AMST), 2020–2026; Director at Galectin Therapeutics (GALT), 2015–2026; Director at Elicio Therapeutics (ELTX), 2021–2022, and 1 more.
The 62 reported transactions were 41 option or other derivative awards, 8 open-market purchases, 4 stock awards and 3 option exercises, plus smaller numbers of other types.
Counted by filing, the open-market trades come to 6 purchases worth about $327K and 1 sale worth about $117K.
The largest open-market purchase was 20,000 shares of AMST at an average $5.00 on September 29, 2020, about $100K.
The only open-market sale was 19,370 shares of GALT at an average $6.02 on September 10, 2018, about $117K.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 7, 2025 | AMST Amesite Inc. | Director | Buy | 3,333 | $3.00 | $9,999.00 | +51.5% | -21.8% | -28.2% | |
| Dec 14, 2021 | AMST Amesite Inc. | Director | Buy | 16,000 | $1.18 | $18,824.80 | +25.9% | -54.7% | -77.4% | |
| Sep 29, 2020 | AMST Amesite Inc. | Director | Buy | 20,000 | $5.00 | $100,000.00 | +48.0% | - | - | |
| May 31, 2019 | GALT Galectin Therapeutics Inc | Director | Buy | 18,578 | $4.28 | $79,513.84 | +38.6% | - | - | |
| Sep 10, 2018 | GALT Galectin Therapeutics Inc | Director | Sell | 19,370 | $6.02 | $116,585.20 | -28.7% | - | - | |
| Mar 21, 2017 | ESPR Esperion Therapeutics, Inc. | Director | Buy | 1,000 | $42.26 | $42,260.00 | New | - | - | |
| Mar 1, 2016 | ESPR Esperion Therapeutics, Inc. | Director | Buy | 5,000 | $15.28 | $76,400.00 | +100.0% | - | - |